4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001193125-26-027396
Options or other derivatives
- Chief Executive Officer acquired 629,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tak Paul Peter · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-26 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +629,000 | 629,000 | D |
Loading xslF345X05/ownership.xml…